Ultrasensitive tumor-informed ctDNA MRD detection to identify metastatic relapse and as predictor of recurrence-free survival following resection of early-stage NSCLC.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Fernando Pikabea Díaz, David M. Kurtz, Jeffrey Gregg, Zachary Coyne, Sameena Khan, Jamie Feng, Thomas K. Waddell, Kazuhiro Yasufuku, Laura Donahoe, Andrew Pierre, Shaf Keshavjee, Jonathan Yeung, Marcelo Cypel, Marc De Perrot, Elliot Wakeam, Mary R. Rabey, Lisa W. Le, Sierra Love Stowell, Maximilian Diehn, Natasha B. Leighl
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7162485725
Cites:
Cited by:
Related to:
